Roche Holding Ltd. (VTX:ROG) has been given a CHF 290 price target by equities research analysts at Jefferies Group LLC in a note issued to investors on Thursday. The brokerage presently has a “buy” rating on the healthcare company’s stock. Jefferies Group LLC’s price objective points to a potential upside of 26.03% from the company’s previous close.

A number of other analysts have also weighed in on ROG. Goldman Sachs Group, Inc. (The) set a CHF 335 price objective on Roche Holding and gave the company a “buy” rating in a research note on Thursday, July 20th. Morgan Stanley set a CHF 260 price target on Roche Holding and gave the stock a “neutral” rating in a research note on Wednesday, July 26th. Sanford C. Bernstein set a CHF 284 price target on Roche Holding and gave the stock a “buy” rating in a research note on Thursday, July 27th. UBS AG set a CHF 260 price target on Roche Holding and gave the stock a “neutral” rating in a research note on Thursday, July 27th. Finally, J P Morgan Chase & Co reaffirmed a “buy” rating and issued a price target on shares of Roche Holding in a research note on Friday, July 28th. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and five have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of CHF 262.69.

Shares of Roche Holding (VTX ROG) opened at CHF 230.10 on Thursday. Roche Holding has a 52 week low of CHF 218.30 and a 52 week high of CHF 273.

ILLEGAL ACTIVITY WARNING: This piece was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece on another website, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be read at https://www.thecerbatgem.com/2017/11/18/roche-holding-ltd-rog-pt-set-at-chf-290-by-jefferies-group-llc.html.

Roche Holding Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche Holding (VTX:ROG)

Receive News & Stock Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related stocks with our FREE daily email newsletter.